Longitudinal Sparse Single‐Omics Factor Analysis for High‐Dimensional Blood Biomarkers in Alzheimer's Disease
Statistics in Medicine · 2026-05 · 45 (10-12)
DOI: 10.1002/sim.70601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 14.05.2026. Verfasst von Haotian Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIMH NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose molecular mechanisms involve multiple biological pathways. Longitudinal blood‐based omics data, such as lipidomics and metabolomics profiles, offer promising noninvasive biomarkers for early detection and prognosis, yet they are high‐dimensional, sparse, and exhibit complex temporal and cross‐feature correlations. The primary goal of this study is to identify which omics data types are most strongly associated with time to dementia onset in patients with mild cognitive impairment (MCI) at baseline. To address this, we propose a longitudinal sparse single‐omics factor analysis (LS‐SOFA) framework that models each omics view through view‐specific latent factors and feature‐weight matrices, with temporal dynamics captured by functional principal component analysis (FPCA). The resulting functional principal component (FPC) scores are incorporated into a survival model to test whether each omics view is associated with time to dementia onset. An efficient covariance‐based estimation algorithm substantially reduces computational and memory cost, enabling large‐scale application in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. In simulations, LS‐SOFA achieves higher longitudinal estimation accuracy and more stable hypothesis testing than competing methods. Applied to five blood‐based omics views from ADNI, LS‐SOFA identified plasma lipidomics and serum metabolomics from FIA and UPLC as significantly associated with dementia risk after FDR adjustment, with nominal evidence of association for gut microbial metabolomics from serum. The top features within each omics view reveal biologically interpretable metabolic pathways that may serve as blood‐based biomarkers for AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
- Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina, USA.
- Duke Institute of Brain Sciences, Duke University, Durham, North Carolina, USA.
- Department of Medicine, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Haotian Zou, Sheng Luo
Förderung
- NIA NIH HHS
- NIMH NIH HHS
- National Institute on Aging
Zitieren
APA
Zou, H., Kaddurah-Daouk, R., Luo, S., & Alzheimer's Disease Neuroimaging Initiative (2026). Longitudinal Sparse Single‐Omics Factor Analysis for High‐Dimensional Blood Biomarkers in Alzheimer's Disease. Statistics in Medicine, 45(10-12). https://doi.org/10.1002/sim.70601
Vancouver
Zou H, Kaddurah-Daouk R, Luo S, Alzheimer's Disease Neuroimaging Initiative. Longitudinal Sparse Single‐Omics Factor Analysis for High‐Dimensional Blood Biomarkers in Alzheimer's Disease. Statistics in Medicine. 2026;45(10-12). doi:10.1002/sim.70601
BibTeX
@article{Zou2026,
author = {Zou, Haotian and Kaddurah-Daouk, Rima and Luo, Sheng and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Longitudinal Sparse Single‐Omics Factor Analysis for High‐Dimensional Blood Biomarkers in Alzheimer's Disease},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {10-12},
doi = {10.1002/sim.70601}
}
EUVIMED